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1. Summary 
 
Maine Revised Statute Title 38, Chapter 16-D: Toxic Chemicals in Children’s Products requires 
the Maine Department of Environmental Protection (MEDEP), in concurrence with the Maine 
Center for Disease Control and Prevention (MECDC), to develop and maintain a list of 
Chemicals of Concern (COC), a list of Chemicals of High Concern (CHC) and subsequently a 
list of priority chemicals which are subject to potential reporting requirements and/or regulation. 
The COC list was developed in 2010 and revised in 2011 according to statutory revisions and 
contains 1,384 chemicals1. The CHC list, which can contain no more than 70 chemicals, was 
derived from the COC list following statutory requirements and a prioritizing methodology 
developed by the MECDC and described in detail in the 2012 Deriving Chemicals of High 
Concern Process documentation2. The CHC list was published in 2012 and listed 49 chemicals of 
high concern. Since 2012, eight chemicals from the CHC list have been designated as priority 
chemicals.  
 
The Toxic Chemicals in Children’s Products statute requires the MEDEP Commissioner to 
update the CHC list once every 3 years3. Per statute, the update requires the removal of 
chemicals from the CHC list that are designated as priority chemicals, as well as removal of 
chemicals that no longer meet the CHC criteria. The statute also permits the MEDEP 
Commissioner to identify additional chemicals of high concern, so long as the chemicals meet 
the CHC listing criteria and the CHC list contains no more than 70 chemicals. 
 
This document presents the first triennial update of the CHC list published in July 2012. The 
triennial update was focused on removing chemicals from the CHC list now designated as 
priority chemicals, and removing chemicals that do not meet the CHC criteria. The updated CHC 
list now contains 36 chemicals. For the 2015 update, 13 chemicals were removed from the 2012 
CHC list. Eight chemicals were removed because they are now listed as priority chemicals. In 
response to petitions to delist specific chemicals, one chemical was removed from the CHC list, 
while another chemical CHC listing was modified. Based on review, four chemicals were 
removed because they do not meet the statutory CHC identification criteria.   
 
The MEDEP and MECDC intend to review and update the CHC selection process to identify 
new chemicals of high concern and subsequent priority chemicals during the next three years. 
One approach under consideration would be to revise the interpretation of weight-of-evidence 
toxicity criteria initially used to generate the 2012 CHC list to meet the standard of “strong 
credible scientific evidence” (e.g., include probable human carcinogens rather than just known 
human carcinogens, consider both category 1A and 1B reproductive classifications by the 
Japanese GHS). This approach would expand the potential CHC list considerably, which would 
then be narrowed based on exposure information, such as biomonitoring data. 
 
                                                           
1
 http://www.maine.gov/dep/safechem/concern/index.html 
 
2
 http://www.maine.gov/dep/safechem/highconcern/index.html 
 
3
 MRS Title 38, Chapter 16-D:TOXIC CHEMICALS IN CHILDREN’S PRODUCTS. 38 §1693-A. Subsection 3. 
http://www.mainelegislature.org/legis/statutes/38/title38ch16-Dsec0.html 
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2. 2012 Derivation of Chemicals of High Concern   
 
The 2012 chemicals of high concern (CHC) identification process began with the list of 
chemicals of concern (COC) published in 2011. The COC list contained 1,384 chemicals that in 
accordance with statute were listed by an authoritative governmental entity on the basis of 
credible scientific evidence4 as being: 
 
A. A carcinogen, a reproductive or developmental toxicant or an endocrine disruptor;  
 
B. Persistent, bioaccumulative and toxic; or  
 
C. Very persistent and very bioaccumulative. 
 
According to statute the CHC list can contain no more than 70 chemicals. Identification of CHC 
requires that the chemical is on the COC list and meets additional toxicity and exposure criteria 
as defined by statute. The toxicity criteria are defined as strong credible scientific evidence that 
the chemical is a reproductive or developmental toxicant, endocrine disruptor or human 
carcinogen. The exposure criteria are defined as strong credible scientific evidence that:  
 
A. The chemical has been found through biomonitoring to be present in human blood, 
including umbilical cord blood, breast milk, urine or other bodily tissues or fluids;  
 
B. The chemical has been found through sampling and analysis to be present in household 
dust, indoor air or drinking water or elsewhere in the home environment; or  
 
C. The chemical is present in a consumer product used or present in the home.   
 
To narrow the list of 1,384 COC to no more than 70 CHC, the MECDC followed an approach 
developed by Washington State for their Children’s Safe Products Act5 and detailed in the 2012 
Deriving Chemicals of High Concern Process documentation. Briefly, Washington State 
identified 476 chemicals that had both evidence of toxicity and exposure from two larger lists (a 
list of 2,044 high priority chemicals, which contained all of the 1,384 chemicals of concern 
identified by the State of Maine, and a list of 2,219 chemicals with evidence of potential child 
exposure). The list of 476 chemicals was reduced to 184 chemicals through removal of 
chemicals that were regulated under existing laws, chemicals that were combustion products, and 
chemicals with limited toxicity data or toxicity primarily concerned with ecological endpoints.  
 
                                                           
4
 Credible scientific evidence is defined by statute as the results of a study, the experimental design and conduct of 
which have undergone independent scientific peer review, that are published in a peer-reviewed journal or 
publication of an authoritative federal or international governmental agency, including but not limited to the 
United States Department of Health and Human Services, National Toxicology Program, Food and Drug 
Administration and Centers for Disease Control and Prevention; the United States Environmental Protection 
Agency; the World Health Organization; and the European Union, European Chemicals Agency. 
 
5
 Washington State’s Children’s Safe Products Act. http://www.ecy.wa.gov/programs/swfa/cspa/ 
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The MECDC then applied a three-step process to the Washington State list of 184 chemicals to 
derive a final CHC list of no more than 70 chemicals. Step 1 included removal of chemicals that 
were not on the State of Maine COC list, chemicals that were already regulated under existing 
Maine directive, or chemicals unlikely to be added to consumer products. Step 2 included 
exclusion of chemicals that did not meet the Maine statutory definition of credible scientific 
evidence (i.e., chemicals that were listed solely by State governments; not by federal or 
international authoritative governmental entities). Step 3 involved the use of toxicity and 
exposure prioritizing criteria developed by the MECDC and MEDEP to identify chemicals that 
met the statutory requirements for chemical of high concern listing (e.g., strong credible 
scientific evidence for toxicity) and to help identify the most potentially harmful chemicals. 
 
After application of Steps 1 and 2, the potential CHC list was narrowed to 107 chemicals. For 
Step 3, multiple databases maintained by federal or international authoritative governmental 
programs were used to narrow the list of 107 potential CHC to no more than 70 CHC (Table 1). 
Database-specific toxicity prioritizing criteria for meeting the test of strong credible scientific 
evidence that the chemical is a reproductive or developmental toxicant, endocrine disruptor or 
human carcinogen were developed and applied (Table 1).  
 
Table 1.  CHC identification databases and applied prioritizing criteria. 
 
Database Prioritizing criteria 
National Toxicology Program Center for Evaluation of 
Risks to Human Reproduction (NTP-CERHR)  
“Serious Concern” or “Concern” for adverse 
effects in humans 
National Toxicology Program  
Report on Carcinogens (NTP-ROC) Known to be a human carcinogen 
Globally Harmonized System of Classification and 
Labelling of Chemicals (GHS) 
Category 1A reproductive hazard 
Category 1A carcinogen 
European Commission Endocrine Disruptor Program 
(EU-EDP) Category 1 endocrine disruptor 
U.S. Environmental Protection Agency Integrated Risk 
Information System (USEPA IRIS)  
1986 category A, 1996, 1999, or 2005 known 
human carcinogen 
European Union List of Carcinogens (EU cancer) Category 1A carcinogen 
International Agency for Research of Cancer (IARC) Group 1 carcinogenic to humans 
 
 
In addition, MECDC considered chemicals that were categorized with credible scientific 
evidence as being persistent, bioaccumulative and toxic (PBT) as candidate CHC, since two of 
the three listing criteria for COC specified in statute were related to being a PBT.  Two PBT lists 
were identified and used to identify potential CHC chemicals (Table 2).  
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Table 2.  Databases and toxicity prioritizing criteria for identifying PBT related chemicals. 
 
Database Prioritizing criteria 
Health Canada Persistent Bioaccumulative and 
inherently Toxic Present on list  
Washington State Persistent Bioaccumulative and 
Toxic 
Present on list and confirmed with review of 
studies published  in peer reviewed 
publications 
 
 
Seven candidate CHC chemicals were identified solely based on a PBT listing. The MECDC 
previously performed extensive reviews of peer-reviewed published studies for four of the seven 
PBT-related chemicals (tetrabromobisphenol A, deca-brominated diphenyl ether, 
hexabromocyclododecane, and perfluorooctane sulfonic acid) and determined there was a 
sufficient body of peer-reviewed publications to conclude there was strong credible scientific 
evidence for either reproductive or developmental toxicity, endocrine disruption, or other toxic 
health effects.   
 
To meet the CHC strong credible scientific evidence criteria for presence in human blood, urine 
or other bodily fluids or presence in household indoor air, dust or drinking water, MECDC 
conducted peer-review literature searches to identify chemical-specific human biomonitoring 
studies or indoor air/dust monitoring studies. For presence in a consumer product used or present 
in the home, the MEDEP examined 12 federal and international authoritative governmental 
databases to identify chemicals present in consumer products.  
 
Forty-nine chemicals were identified from the list of 107 potential CHC that met both the 
toxicity and exposure prioritizing criteria. These 49 chemicals became the list of Chemicals of 
High Concern published on July 1, 2012. 
 
 
3. 2015 Triennial Update 
 
By statute, the MEDEP Commissioner is required to review the CHC list every three years and 
remove any chemical from the CHC list that has been designated a priority chemical or that no 
longer meets the listing criteria.6  Additional chemicals may be added to the CHC list according 
to the listing requirements. The final list is to include no more than 70 chemicals and no fewer 
than 10.  The 2015 CHC update consisted of an initial review to confirm the current status of 
chemical listings by authoritative national and international agencies, identify and remove 
chemicals that had been designated as priority chemicals, and identify and remove any chemicals 
not meeting the listing criteria. This update additionally identified and addressed a number of 
minor corrections to documentation that do not change any chemical’s current CHC status. 
 
 
                                                           
6
 MRS Title 38, Chapter 16-D:TOXIC CHEMICALS IN CHILDREN’S PRODUCTS, 38 §1693-A Subsection 3. 
http://www.mainelegislature.org/legis/statutes/38/title38ch16-Dsec0.html 
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3.1. Chemicals of High Concern delisting 
  
The delisting of chemicals from the CHC list is based on the removal of chemicals now listed as 
priority chemicals and chemicals not meeting the CHC listing requirements. Chemicals that do 
not meet the statutory CHC identification criteria were identified by chemical-specific petitions 
to delist chemicals from the CHC list or by the MECDC as not meeting the CHC identification 
criteria following review for the three year update. 
 
 
3.1.1. Removal of chemicals listed as priority chemicals  
 
Since the publication of the CHC list in 2012, eight CHC have been elevated from CHC status to 
priority chemical status (Table 3). These eight chemicals have gone through the priority chemical 
designation process and are now listed as priority chemicals. Due to their priority chemical 
listing status these chemicals were removed from the CHC list.  
 
Table 3. Chemicals of high concern removed due to priority chemical listing status. 
 
Chemical CAS number Year of priority status designation 
Arsenic and arsenic compounds 7440-38-2 2014 
Mercury and mercury compounds 7439-97-6 2014 
Cadmium 7440-43-9 2014 
Diethyl phthalate 84-66-2 2015 
Dibutyl phthalate 84-74-2 2015 
Benzyl Butyl phthalate 85-68-7 2015 
Di-(2-ethylhexyl) phthalate 117-81-7 2015 
Formaldehyde 50-00-0 2015 
 
 
3.1.2. Removal of chemicals not meeting the CHC identification criteria 
 
Table 4.  Chemicals of high concern delisted because they do not meet the CHC criteria. 
 
Chemical CAS number Reason for delisting 
Beryllium and beryllium 
compounds  7440-41-07 
Biomonitoring and presence in consumer 
products data did not meet the finding of strong 
credible scientific evidence  
Metallic nickel a 7440-02-0 Does not meet the toxicity prioritizing criteria of 
a known human carcinogen. 
Di-n-hexyl phthalate  84-75-3 Does not meet current toxicity prioritizing 
criteria used to identify CHC 
Hexachlorobutadiene 87-68-3 Only listed as a PBT with no formal review 
Tris(2-chloroethyl) phosphate  115-96-8 Only listed as a PBT with no formal review 
2-Naphthalenol, 1-[(4-methyl-2-
nitrophenyl)azo]- 2425-85-6 Only listed as a PBT with no formal review 
a
 Nickel compounds (CAS N/A) remain on the CHC list as they meet CHC identification criteria.  
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Beryllium and beryllium compounds (CAS 7440-41-07) 
 
In response to a recent petition7 to remove beryllium and beryllium compounds from the CHC 
list, MECDC concurred with MEDEP that beryllium and beryllium compounds do not meet the 
CHC identification criteria due to insufficient biomonitoring data and the apparent lack of data 
related to exposure in the home or use in children’s products8. As such, beryllium and beryllium 
compounds were removed from the CHC list during the 2015 update. While beryllium and 
beryllium compounds were removed from the CHC list, they remain on the COC list as they 
appropriately meet COC eligibility criteria.  
 
Metallic nickel (CAS 7440-02-0) 
 
The listing of nickel and nickel compounds (CAS 7440-02-0) as a CHC was challenged through 
petition9 in 2014. Nickel and nickel compounds were identified on the 2012 CHC list under a 
single CAS number 7440-02-0, which specifically identifies only metallic nickel. However, 
metallic nickel itself does not meet the CHC criteria for strong credible scientific evidence of 
carcinogenicity10. Based on the CHC prioritizing toxicity criteria, metallic nickel should not be 
included on the final CHC list, as currently the CHC prioritizing toxicity criteria used for 
carcinogens is the chemical must be listed by an authoritative federal or international 
governmental agency as a known human carcinogen. Metallic nickel is listed as reasonably 
anticipated to be a human carcinogen. Accordingly, metallic nickel CAS 7440-02-0 was removed 
from the CHC list as it does not meet the CHC identification criteria. Removal of metallic nickel 
from the CHC list does not warrant removal from the COC list, as metallic nickel following 
current COC eligibility criteria is appropriately identified as chemical of concern. 
 
Nickel compounds as a class are listed by authoritative federal and international governmental 
agencies as known human carcinogens and thus appropriately meet the toxicity inclusion criteria 
for CHC listing8. Consequently, nickel compounds will remain on the CHC list. As there is no 
single CAS number to identify nickel compounds as a group, the CHC listing for nickel 
compounds will not have an associated CAS number on the COC and CHC lists.  
 
 
 
 
                                                           
7
 “Petition to Remove Beryllium and Compounds from the Maine DEP List of Chemicals of Concern and from the 
List of Chemicals of High Concern under the Maine Toys and Children’s Products Law” submitted by Materion June 
6
th
, 2014. 
 
8
 MECDC review of the “Petition requesting the removal of beryllium and beryllium compounds from the Toxic 
Chemicals in Children’s Products list of Chemicals of Concern and Chemicals of High Concern”, memorandum 
submitted to the MEDEP December 3
rd
, 2015.   
 
9
 “Petition to Remove Nickel and Nickel Compounds from the Maine Kid’s Safe Products Act” submitted by the 
Nickel Institute July 28
th
, 2014.   
 
10
 MECDC review of the “Petition to Remove Nickel and Nickel Compounds from the Maine Kid’s Safe Products 
Act”, memorandum submitted to the MEDEP January 23
rd
, 2015.   
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Di-n-hexyl phthalate (CAS 84-75-3) 
 
The National Toxicology Program’s Center for the Evaluation of Risks to Human Reproduction 
(NTP-CERHR) previously published a number of monographs assessing the potential human 
reproductive and developmental health effects of specific chemicals, including several 
phthalates11. The NTP-CERHR monographs were used as a database to identify CHC that met 
the statutory requirement of strong credible scientific evidence for human reproductive or 
developmental toxicants (Table 1), if NTP-CERHR determined there was “Serious Concern” or 
“Concern” for adverse effects in humans. The NTP-CERHR used a two phase process to classify 
the weight-of-evidence for potential human reproductive and/or developmental health effects12. 
Phase 1 consisted of a weight-of-evidence approach for hazard identification with a seven-tier 
classification scale as follows: Clear evidence of adverse effects; Some evidence of adverse 
effects; Limited evidence of adverse effects; Insufficient evidence for a conclusion; Limited 
evidence of no adverse effects; Some evidence of no adverse effects; Clear evidence of no 
adverse effects. For Phase 1 hazard identification, the weight-of-evidence for effects in 
laboratory animals and humans were classified separately. Phase 2 consisted of combining the 
hazard identification outcomes for experimental animal studies and human studies, if available, 
with current human exposure data or pharmacokinetic data needed to extrapolate results 
observed in experimental animals to potential effects in humans to generate a final “Level of 
Concern”.  The Phase 2 level of concern of adverse effects in humans were broken down  into 
five categories: Serious concern for adverse effects; Concern for adverse effects; Some concern 
for adverse effects; Minimal concern for adverse effects; Negligible concern for adverse effects 
and a sixth category for insufficient data on hazard identification and/or exposure.  
 
In the 2012 Deriving Chemicals of High Concern documentation the toxicity prioritizing criteria 
for CHC identification for chemicals with NTP-CERHR monographs is listed as “Clear” or 
“Some” evidence of adverse effects in humans. Although the NTP-CERHR prioritizing criteria 
as defined in the 2012 documentation is not clear regarding the use of Phase 1 or Phase 2 
classifications, the intent was to identify chemicals with strong evidence of adverse reproductive 
or developmental health effects in humans.  
 
For di-n-hexyl phthalate (DnHP) (CAS 84-75-3), the NTP-CERHR concluded for Phase 1 hazard 
identification that there was “Clear evidence of adverse effects” for reproductive toxicity and 
“Limited evidence of adverse effects” for development toxicity in laboratory animals, and a lack 
of data to assess the weight-of-evidence of adverse effects in humans13. The NTP-CERHR Phase 
2 conclusion for the level of concern in humans was “Insufficient hazard and/or exposure data” 
13
. Both Phase 1 and Phase 2 assessments concluded that there is insufficient data to assess the 
potential reproductive or developmental health effects of DnHP in humans. Consequently, DnHP 
                                                           
11
 Jahnke, G.D., Iannucci, A.R., Scialli, A.R., and Shelby, M.D. 2005. Center for the Evaluation of Risks to Human 
Reproduction-The First Five Years. Birth Defects Research (Part B) 74:1–8. 
 
12
 Bucher, J.R., Wolfe, M.S., Thayer, K. 2011. National Toxicology Program: Evaluation of Reproductive and 
Developmental Hazards. http://www.oehha.ca.gov/prop65/public_meetings/pdf/071211NTPCalEPADART.pdf 
 
13
 NTP-CERHR. 2003. NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of 
Di-n -Hexyl Phthalate (DnHP). NIH Publication No. 03-4489. 
http://ntp.niehs.nih.gov/ntp/ohat/phthalates/dnhp/dnhp_monograph_final.pdf 
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does not meet the current MECDC toxicity prioritizing criteria designed to identify chemicals 
with strong evidence of adverse reproductive or developmental health effects in humans. The 
2012 CHC selection process mistakenly recorded DnHP as meeting the prioritizing criteria for 
the Phase 2 NTP-CERHR evaluation, when in fact it only met “Clear” evidence of adverse 
effects for the Phase 1 evaluation for experimental animals. Consequently, the CHC listing of 
DnHP (CAS 84-75-3) as a reproductive or developmental toxicant under the NTP-CERHR 
database was removed in the 2015 update.  
 
In the 2012 CHC selection process DnHP did not meet any of the toxicity prioritizing criteria in 
any of the additional toxicity databases used to identify chemicals of high concern. For the 2015 
triennial update all of the toxicity databases were reviewed for potential updates since 2012 that 
would apply to listing DnHP as a chemical of high concern. The Japanese GHS database for 
reproductive health effects does not include any classification for DnHP. The European Union 
(EU) Endocrine Disruptor database continues to lists DnHP as a Category 2 endocrine disruptor. 
Only Category 1 endocrine disruptors from the EU endocrine disruptor list were considered for 
CHC designation. The NTP, IARC, IRIS 1986, IRIS 1996 or the EU carcinogen databases do not 
include classifications for DnHP.  Following the 2012 CHC prioritizing criteria, DnHP does not 
meet the toxicity prioritizing criteria within any database used to identify chemicals of high 
concern and was removed from the CHC list. Removal from the CHC list does not affect the 
listing of DnHP as a chemical of concern. While DnHP was removed from the CHC list for the 
2015 three-year update, this chemical may be listed as a CHC following review and use of 
additional toxicity databases as described in the Identifying New Chemical of High Concern 
section.  
 
Hexachlorobutadiene (CAS 87-68-3), Tris(2-chloroethyl) phosphate (CAS 115-96-8), and 2-
Naphthalenol, 1-[(4-methyl-2-nitrophenyl)azo]- (CAS 2425-85-6) 
 
As part of the triennial review, MECDC identified three chemicals that were listed as CHC 
solely based on the criteria of persistent, bioaccumulative, and toxic (PBT). While PBT is a clear 
toxicity criterion for the COC list, it is not a criterion for listing as a CHC. Hexachlorobutadiene, 
tris(2-chloroethyl) phosphate, and 2-Naphthalenol, 1-[(4-methyl-2-nitrophenyl)azo]- are on the 
2012 CHC list due to their exclusive presence on Washington State’s PBT list and/or Health 
Canada’s PBiT list. However, MECDC has not undertaken a substantial review of the peer-
reviewed scientific literature regarding carcinogenic, reproductive and/or developmental, or 
endocrine disrupting health effects for these chemicals. The toxicity database listings for these 
three chemicals were reviewed for any potential updates or changes and in 2015 they do not meet 
any of the toxicity prioritizing criteria other than being listed as PBTs (i.e., none are known 
human carcinogens, none are listed by NTP-CERHR as reproductive or development toxicants 
with Serious Concern or Concern for adverse effects in humans and none are listed as Category 1 
endocrine disruptors). Accordingly, hexachlorobutadiene, tris(2-chloroethyl) phosphate, and 2-
Naphthalenol, 1-[(4-methyl-2-nitrophenyl)azo]- were removed from the CHC list as they do not 
meet the statutory CHC toxicity criteria, which do not include bioaccumulative or persistent 
criteria. These chemicals remain on the COC list as they appropriately meet statutory COC 
listing criteria.  
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Four additional chemicals are listed as CHC (Tetrabromobisphenol A (CAS 79-94-7), BDE-209 
(CAS 1163-19-5), hexabromocyclododecane (CAS 25637-99-4), perfluoroocatane sulfonic acid 
and its salts (CAS 1763-23-1)) due to their listing as PBTs by Washington State or Health 
Canada. However, MECDC previously reviewed these chemicals and concluded that they met 
the toxicity listing criteria for CHC with strong credible scientific evidence. 
Tetrabromobisphenol A and hexabromocyclododecane have previously undergone review by the 
MECDC for listing as priority chemicals for brominated flame retardants in 201014 and BDE-209 
was reviewed for legislation passed in 200715 banning specific brominated flame retardants.    
 
For perfluorooctane sulfonic acid (PFOS) and its salts, the MECDC in the process of developing 
a drinking water guidance value for perfluorooctanoic acid (PFOA) and PFOS performed a 
review of the current scientific literature published in peer-reviewed journals. Through this 
process the MECDC identified multiple peer-reviewed scientific studies documenting endocrine 
disrupting effects and adverse reproductive and developmental effects in animals16. There were 
also a number of epidemiological studies identified that demonstrated adverse reproductive and 
developmental effects associated with PFOS in humans16. Based on this previous work and 
review the MECDC concluded that PFOS meets the toxicity criteria of an endocrine disruptor 
and reproductive or developmental toxicant with strong credible scientific evidence to be 
appropriately listed as a CHC. For the 2015 triennial update, the chemical-specific inclusion 
criteria (Appendix I) contains toxicity criteria references for PFOS in support of its CHC listing. 
 
 
3.2. General updates 
 
A number of general updates were made to the 2012 CHC list in this update. These represent 
minor changes or corrections and do not change any chemical’s current CHC status. 
 
3.2.1. Database classification updates 
 
There are several chemicals in which the original 2012 CHC listing failed to include an 
appropriate toxicity prioritization from an individual database. For example, benzene is listed in 
NTP, IRIS, EU, IARC and GHS databases as a known human carcinogen; however, the 2012 
CHC list and documentation failed to capture the GHS known human carcinogen categorization. 
Several of these types of database updates were made in the 2015 update (Table 5).  
 
 
 
 
 
                                                           
14
 Rationale for Concurrence by Maine Center for Disease Control and Prevention on the Designation of 
Brominated Flame Retardants as a Priority Chemical, November 22, 2010. 
 
15
 Brominated Flame Retardants: Third annual report to the Maine Legislature, Prepared by the Maine Center for 
Disease Control & Prevention and the Maine Department of Environmental Protection, January 2007. 
 
16
 See Appendix I 2015 Triennial Update Chemical Specific Inclusion Criteria for specific references.  
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Table 5.  Toxicity database classification updates. 
 
Chemical CAS number Toxicity database correction 
Benzene 71-43-2 Added GHS known human cancer categorization 
2-Naphthylamine 91-59-8 Added GHS known human cancer categorization 
Benzidine and its salts 92-87-5 
Added NTP known human cancer categorization; 
Added GHS Category 1A cancer categorization; 
Added European Union Category 1A cancer 
categorization 
1, 2-Dibromoethane 106-93-4 
Removed the IRIS 1996 cancer classification; it 
is classified as likely to be carcinogenic to 
humans, not known to be a human carcinogen 
Nickel compounds No CAS available Added IARC Group 1 carcinogenic to humans 
categorization  
 
 
3.2.2. COC and CHC nomenclature updates 
 
Two general updates were made regarding how specific chemicals are identified by name on the 
final CHC list, as the naming convention of several CHC was not consistent between the COC 
and CHC lists.  
 
Perfluorooctane sulfonic acid (CAS 1763-23-1) 
 
Perfluorooctane sulfonic acid and its associated salts are identified on the COC lists as “Acid 
[Perfluorooctane sulfonates (PFOS)]”; while on the CHC list they are identified as 
“Perfluorooctanyl sulphonic acid and its salts”. The COC and CHC nomenclature for PFOS was 
meant to capture the parent chemical, (i.e., perfluorooctane sulfonic acid) and structurally 
analogous salts that disassociate or breakdown into the parent chemical, such as perfluorooctane 
sulfonic acid potassium salt. The COC nomenclature, Acid [Perfluorooctane sulfonates (PFOS)], 
intended to capture the associated salt compounds through use of the term sulfonates, which 
denotes any salt of a sulfonic acid. The CHC nomenclature directly lists the parent chemical, 
perfluorooctanyl sulphonic acid and then includes the associated salts. For consistency between 
the COC and CHC lists, the identification by chemical name of perfluorooctane sulfonic acid and 
its associated salts was changed to “Perfluorooctane sulfonic acid (PFOS) and its salts” on both 
the COC and CHC lists. The perfluorooctane sulfonic acid nomenclature is the standard 
terminology used by the U.S. National Library of Medicine Hazardous Substances Database17. 
Identification by CAS number on both COC and CHC lists remains as 1763-23-1, which 
specifically identifies perfluorooctane sulfonic acid17. Compound-specific CAS numbers for 
perfluorooctane sulfonic acid salts are not included for CAS number identification for PFOS.  
 
 
 
                                                           
17
 U.S. National Library of Medicine Hazardous Substances Database, Perfluorooctane sulfonic acid CASRN: 1763-
23-1.  http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/f?./temp/~9gR4Dw:1 
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Quartz (CAS 14808-60-7) 
 
Quartz is identified by name on the COC list as “Silica, crystalline (inhaled in the form of quartz 
or cristobalite from occupational sources)” and by CAS number as 14808-60-7. On the CHC list 
quartz is identified by name as “Quartz” and by CAS number as 14808-60-7. The three toxicity 
prioritizing databases used to identify quartz/silica as a chemical of high concern use the 
following nomenclature and CAS numbers: NTP - “Silica, Crystalline (Respirable Size)” CAS 
No.: none assigned; IARC - “Crystalline silica in the form of quartz or cristobalite dust” no 
separate CAS numbers listed; GHS - “Quartz” CAS 14808-60-7. For consistency between the 
COC and CHC lists and the naming conventions used by federal and international authoritative 
governmental agencies, the chemical name for quartz was updated to “Silica, crystalline (in the 
form of quartz or cristobalite dust)” on both the COC and CHC lists. Identification by CAS 
number remains unchanged as 14808-60-7. 
 
Chemicals listed with accompanying salts 
 
Two chemicals on the CHC list are listed as a single chemical with associated salts compounds, 
Benzidine and its salts (CAS 92-87-5) and Perfluorooctane sulfonic acid (PFOS) and its salts 
(CAS 1763-23-1). For these two chemicals a clerical note was added to the COC and CHC lists 
describing that the listed CAS number is specific for the parent chemical, but the listing 
encompasses all parent chemical related salts. The salts have individual salt-specific CAS 
numbers separate from the parent chemical CAS number, but they are not individually listed.     
 
 
3.2.3. 2012 Deriving chemicals of high concern process documentation corrections and 
updates 
 
During the triennial review several minor documentation and reference errors in the 2012 
MECDC Deriving Chemicals of High Concern Process document were identified. Several 
reference updates to documentation were also identified (e.g., the latest NHANES biomonitoring 
data). These errors and updates are described below as general documentation corrections, 
reference corrections, and reference updates. 
 
General documentation corrections 
 
In Figure 2 of the 2012 State of Maine Chemicals of High Concern Prioritization Process, the 
wording in the second bullet under the Step 3 exclusion criteria (“Chemicals with low toxicity 
values from U.S. EPA’s IRIS data base”) was revised to read “Chemicals with low toxicity 
values from ATSDR or RTECs databases”. The ATSDR and RTEC databases were used by 
Washington State to identify chemicals with low toxicity values rather than the IRIS database. 
 
Di-n-hexyl phthalate (DnHP) (CAS 84-75-3) was identified in Table 6 of the 2012 CHC 
documentation as listed by the State of Washington only because of its presence on California’s 
PROP 65 list as reproductive or developmental toxicants. This is incorrect. DnHP is listed by an 
authoritative federal governmental agency, the NTP-CERHR, and should not be listed in Table 6 
in the 2012 process documentation. The NTP-CERHR lists DnHP as having “Clear evidence of 
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adverse effects” for reproductive toxicity and “Limited evidence of adverse effects” for 
developmental toxicity in laboratory animals, and a lack of data to assess the weight-of-evidence 
of adverse effects in humans.18 Due to this NTP-CERHR toxicity listing, DnHP was 
appropriately listed as a COC and remained in the potential CHC selection pool in 2012. 
However, as described in section 3.1.2 above, following review for the 2015 update, it was 
determined that DnHP did not meet the CHC listing criteria and was removed from the 2015 
CHC list, while remaining on the COC list. 
 
The abbreviation for Globally Harmonized System of Classification and Labelling of Chemicals 
(GHS) in the 2012 Appendix I - Deriving Chemicals of High Concern Process Documentation 
and 2012 Appendix II - Final List of Chemicals of High Concern was corrected from GSH to 
GHS in the 2015 appendices.  
 
Reference corrections 
 
The 2012 CHC listing for 2-naphthylamine included one reference for indoor air/dust exposure, 
Wilson, W. E., Lioy, P. J. (1994). "Sources of organic acids in indoor air: a field study." Journal 
of Exposure Analysis and Environmental Epidemiology 4(1): 25-47. However, there is no 
mention of 2-naphthylamine measurement in indoor air or dust or any type of monitoring for 2-
naphthylamine in this publication or additional publications from these authors. The reference as 
listed in Appendix III is also missing an author, it should have been Zhang, J., Wilson, W. E., 
Lioy, P. J.. This reference was removed from the CHC listing as a reference for the presence of 
2-naphthylamine in indoor air or dust. Removal of this reference does not warrant the removal of 
2-naphthylamine from the CHC list, as it meets both toxicity criteria as a known human 
carcinogen and exposure criteria as present in consumer products. 
 
Reference updates 
 
The reference link for the European Commission Endocrine Disruptor Program was updated to: 
http://ec.europa.eu/environment/chemicals/endocrine/documents/index_en.htm#SubThemes5 
 
For the chemical-specific inclusion criteria, the 2005 and 2009 CDC/NHANES biomonitoring 
data references were updated to 2015 data references. For each chemical that listed a 
CDC/NHANES biomonitoring reference, the latest 2015 NHANES biomonitoring report was 
reviewed to ensure that the specific chemical of high concern continues to be detected in human 
blood or urine. Appendix I - 2015 Chemical-Specific Inclusion Criteria, includes the most recent 
updates to biomonitoring and indoor dust/air monitoring references identified for individual 
CHC.  
 
 
 
 
 
                                                           
18
 NTP-CERHR. 2003. NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of 
Di-n -Hexyl Phthalate (DnHP). NIH Publication No. 03-4489. 
http://ntp.niehs.nih.gov/ntp/ohat/phthalates/dnhp/dnhp_monograph_final.pdf 
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4. Identifying New Chemicals of High Concern 
 
4.1. Challenges to identifying new chemicals of high concern 
 
In the 2012 CHC derivation process, the toxicity prioritizing criteria were focused on top-tier 
toxicity classifications used in individual toxicity databases, as a way to identify chemicals with 
strong credible scientific evidence.  For carcinogens, for example, only known human 
carcinogens classified by the NTP or IARC were considered (Table 1). Similar top-tier 
classifications were used to identify reproductive or developmental toxicants and endocrine 
disruptors (Table 1). These top-tier toxicity classifications were also relied upon to narrow the 
list of potential CHC from 107 to fewer than 70 chemicals. While the application of the top-tier 
toxicity prioritizing criteria was efficacious in meeting these objectives, the chosen criteria may 
have been overly stringent in identifying chemicals of high concern. Additionally, the 2012 CHC 
derivation process identified only two authoritative databases for reproductive and/or 
developmental toxicants with weight-of-evidence determinations. One of these authoritative 
databases no longer works to exclusively evaluate and identify reproductive and developmental 
toxicants and does not appear to be currently involved in evaluations of any new chemicals.19 
Only one authoritative government list of endocrine disruptors was identified, and there appears 
to have been no new activity in recent years to add chemicals to this list or revise the 
categorization methodology.   
 
 
4.2. Potential strategies to identify new chemicals of high concern 
 
4.2.1. Toxicity classification strategies 
 
Typically, chemicals that meet top-tier toxicity classifications, such as a known human 
carcinogen, have both human exposure and human health effects data to demonstrate a causal 
relationship. These data are commonly from occupational studies where chemical exposures are 
generally far greater in frequency and amount than most non-occupational exposures. Chemicals 
falling into a second-tier toxicity classification, such as reasonably anticipated to be a human 
carcinogen, typically have substantial data demonstrating adverse health effects in experimental 
animals with some exposure data in humans demonstrating a potential for human exposure, but 
limited or no human health data to validate a causal relationship. It is not necessarily the case 
that chemicals with lesser toxicity classifications are less harmful than chemicals with a higher 
toxicity classification. It may simply be that there is less information available regarding adverse 
health effects specifically observed in humans.  
 
One way to identify additional CHC would be to adopt the second highest weight-of-evidence 
determination as representing strong credible scientific evidence. While credible scientific 
evidence is defined in the statute, strong credible scientific evidence is neither defined in the 
statute or in rule. The MECDC feels that the use of a second-tier toxicity classification coupled 
with sound evidence that the chemical is commonly detected in humans would satisfy the criteria 
of strong credible scientific evidence for CHC identification. Chemicals of concern that meet a 
                                                           
19
 http://ntp.niehs.nih.gov/pubhealth/hat/noms/index.html  
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second-tier carcinogen or reproductive or developmental toxicant classification could then be 
evaluated further to determine if there are relevant human exposure data, such as USCDC 
NHANES biomonitoring data. If the chemical meets a second-tier toxicity classification by a 
federal or international authoritative governmental agency and is found in humans through either 
large scale national biomonitoring studies or relevant peer-reviewed scientific studies, the 
chemical may be considered for CHC listing pending information about presence in products.   
 
This approach would be a large undertaking, and there would be a need to develop either 
additional toxicity or exposure criteria to constrain the list to the required 70 chemicals. For 
example, for carcinogens alone, the NTP classifies nearly 200 chemicals as reasonably 
anticipated to be human carcinogens. 
 
Table 6.  Potential toxicity prioritizing criteria expansions to identify chemicals of high concern.  
 
Database Second-tier cancer classifications 
Carcinogenesis 
NTP ROC Reasonably anticipated to be a human carcinogen 
USEPA IRIS B1 probable human carcinogen (1986 guidelines)  Likely to be carcinogenic to humans (1999 and 2005 guidelines) 
Japanese GHS Category 1B presumed to have carcinogenic potential for humans 
EU Cancer Category 1B presumed to have carcinogenic potential for humans 
IARC Group 2A probably carcinogenic to humans 
Reproductive or developmental toxicity 
Japanese GHS Category 1B presumed human reproductive toxicant 
 
 
4.2.2. Strategies focusing on reproductive and developmental toxicity 
 
The MECDC utilized two databases, the NTP-CERHR and the Japanese GHS, to identify 
chemicals of high concern that were reproductive or developmental toxicants. In 2011 the NTP-
CERHR was reorganized into the Office of Health Assessment and Translation (OHAT). OHAT 
has the same general mission as the previous CERHR, but expanded to evaluate additional health 
effects. Since the 2011 transition OHAT has not published a formal chemical evaluation. To 
strengthen the CHC selection process for chemicals that exhibit reproductive or developmental 
toxicities, the MECDC would like to review the feasibility of using the USEPA IRIS and EU 
REACH databases for identifying chemicals of high concern based on reproductive and/or 
developmental health effects. The USEPA IRIS database, which is currently used to identify 
human carcinogens, also derives health-based reference doses for non-cancer toxicities such as 
reproductive and developmental endpoints. The EU REACH database maintains a Candidate List 
of Substances of Very High Concern which lists chemicals that have been reviewed and 
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identified as “Toxic for reproduction”. These two databases could be examined to determine if 
any COC are currently classified as reproductive or developmental toxicants and whether or not 
they would meet CHC identification criteria.  
 
 
4.2.3. Endocrine disruptors 
 
For endocrine disrupting status the MECDC relied on the only authoritative federal or 
international governmental database available that categorically classifies endocrine disrupting 
chemicals, the EU endocrine disruptor database. The EU list did not use a weight-of-evidence 
approach to classify potential endocrine-disrupting chemicals. Rather they defined endocrine-
disrupting chemicals as Category 1: evidence of endocrine-disrupting activity in at least one 
species using intact animals; Category 2: at least some in vitro evidence of biological activity 
related to endocrine disruption; Category 3: no evidence of endocrine-disrupting activity or no 
data available20. While it was not a formal weight-of-evidence approach, chemicals that were 
classified as Category 1 endocrine disruptors were included as potential CHC largely because the 
EU endocrine disrupting list is the only authoritative federal or international governmental 
database available to identify potential endocrine-disrupting chemicals. Currently, the MECDC 
does not feel that it would be appropriate to expand the endocrine disruptor toxicity prioritizing 
criteria for the EU endocrine disruptor list because the classification method is not a robust 
weight-of-evidence approach and the Category 2 classification requires only some evidence of 
biological activity in vitro, not in intact animals or humans. It is also unclear whether or not this 
database is being updated as new chemical-specific information regarding endocrine disruption 
is made available. Short of an extensive chemical-by-chemical review for potential endocrine 
disrupting health effects, there remains a deficiency in the CHC selection process regarding 
identification of endocrine-disrupting chemicals. 
                                                           
20
 http://ec.europa.eu/environment/chemicals/endocrine/strategy/substances_en.htm 
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Table 7.  2015 Chemicals of High Concern. 
CAS Number Chemical Name 
71-43-2 Benzene 
75-01-4 Vinyl chloride 
79-94-7 Tetrabromobisphenol A 
84-61-7 Dicyclohexyl phthalate; DCHP 
91-59-8 2-Naphthylamine 
92-69-3 4-Hydroxybiphenyl; 4-Phenylphenol 
92-87-5* Benzidine and its salts 
94-13-3 Propyl paraben 
94-26-8 Butyl paraben 
95-53-4 2-Aminotoluene 
99-76-3 Methyl paraben 
99-96-7 p-Hydroxybenzoic acid 
100-42-5 Styrene 
101-14-4 4,4´-Methylenebis(2-Chloroaniline) 
106-89-8 Epichlorohydrin 
106-93-4 1,2-Dibromoethane 
106-99-0 1,3-Butadiene 
108-88-3 Toluene 
118-74-1 Hexachlorobenzene 
120-47-8 Ethyl paraben 
131-55-5 Benzophenone-2 (Bp-2), 2,2',4,4'-tetrahydroxybenzophenone 
131-56-6 2,4-Dihydroxybenzophenon; Resbenzophenone 
131-70-4 Mono-n-butylphthalate 
140-66-9 4-tert-Octylphenol; 1,1,3,3-Tetramethyl-4-butylphenol 
556-67-2 Octamethylcyclotetrasiloxane 
608-93-5 Benzene, pentachloro- 
1163-19-5 2,2',3,3',4,4',5,5',6,6'-Decabromodiphenyl ether; BDE-209 
1634-04-4 Methyl tert-butyl ether; MTBE 
1763-23-1* Perfluorooctane sulfonic acid (PFOS) and its salts 
1806-26-4 Phenol, 4-octyl- 
5466-77-3 2-ethyl-hexyl-4-methoxycinnamate 
14808-60-7 Silica, crystalline (in the form of quartz or cristobalite dust) 
25013-16-5 Butylated hydroxyanisole 
25637-99-4 Hexabromocyclododecane 
27193-28-8 Phenol, (1,1,3,3-tetramethylbutyl)-; Octylphenol 
No CAS Nickel compounds 
 
*CAS numbers are specific for the parent chemical, but the CHC listing includes both the parent chemical and 
parent chemical-related salt compounds.  
 
